These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3580020)

  • 21. Different antimicrobial agents in treatment and prophylaxis of experimentally induced intraabdominal sepsis.
    Lahnborg G; Nord CE
    Scand J Gastroenterol Suppl; 1984; 100():10-5. PubMed ID: 6592741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Kamysz W; Rocchi M; D'Amato G; Mocchegiani F; Silvestri C; Łukasiak J; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):207-16. PubMed ID: 15629532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects and side effects of taurolin in experimental peritonitis in the rat].
    Hart H; Seifert J; Brendel W
    Langenbecks Arch Chir; 1986; 368(3):149-62. PubMed ID: 3807498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Condie RM; Cerra FB
    Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
    Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
    Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of gammaglobulin preparations on in vitro immunoglobulin production induced by pokeweed mitogen].
    Hashimoto F
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):64-71. PubMed ID: 6201426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative in vitro study of low pH and enzyme treated immunoglobulin preparation for intravenous use.
    Nisini R; Le Moli S; Matricardi PM; Fattorossi A; D'Amelio R
    J Clin Lab Immunol; 1989 Aug; 29(4):193-7. PubMed ID: 2517759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic immunoglobulin (IgG) infusions in infants.
    Itami N; Akutsu Y; Kusunoki Y; Tochimaru H; Takekoshi Y
    Clin Nephrol; 1990 Mar; 33(3):153. PubMed ID: 2323115
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of intravenous immunoglobulin for the treatment of infection: an overview.
    Yap PL
    J Infect; 1987 Jul; 15 Suppl 1():21-8. PubMed ID: 3117897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation criteria for intravenous immunoglobulin G preparations].
    Nydegger UE
    Presse Med; 1983 Nov; 12(41):2619-24. PubMed ID: 6228800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties and characteristics of a new immunoglobulin G intravenous preparation. A symposium. Chicago, Illinois, June 7, 1985.
    Rev Infect Dis; 1986; 8 Suppl 4():S371-463. PubMed ID: 3092302
    [No Abstract]   [Full Text] [Related]  

  • 34. Controversies in the use of passive immunotherapy for bacterial infections in the critically ill patient.
    Baumgartner JD; Glauser MP
    Rev Infect Dis; 1987; 9(1):194-205. PubMed ID: 3547572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic effect of a new human immunoglobulin SM-4300 on the severe infections in surgical patients].
    Nakayama I; Kawaguchi H; Yamaji E; Akieda Y; Itokawa K
    Jpn J Antibiot; 1985 Sep; 38(9):2617-21. PubMed ID: 3935829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three generations of immunoglobulin G preparations for clinical use.
    McCue JP; Hein RH; Tenold R
    Rev Infect Dis; 1986; 8 Suppl 4():S374-81. PubMed ID: 3092303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pentaglobin and piperacillin on survival in a rat model of faecal peritonitis: importance of intervention timings.
    Jacobs S; Sobki S; Morais C; Tariq M
    Acta Anaesthesiol Scand; 2000 Jan; 44(1):88-95. PubMed ID: 10669278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of intravenous immunoglobulin preparations against viral and bacterial infections in mouse protection tests.
    Stephan W; Dichtelmüller H
    Infection; 1983; 11(4):227-31. PubMed ID: 6618678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous administration of human immune globulin.
    Rutherford C
    J Intraven Nurs; 1989; 12(5):307-9. PubMed ID: 2795332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclass composition of intravenous IgG preparations.
    Skvaril F
    Monogr Allergy; 1986; 19():266-76. PubMed ID: 2429172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.